by Matthew Perrone Credit: Unsplash/CC0 Public Domain U.S. health regulators on Monday granted full approval to Moderna’s COVID-19 vaccine, a shot that’s already been given to tens of millions of Americans since its emergency authorization over a year ago. The action by the Food and Drug Administration means the agency has completed the same rigorous,...
by Sarah Avery, Duke University Credit: Pixabay/CC0 Public Domain A booster dose of Moderna’s COVID-19 vaccine showed signs of waning antibody levels against the omicron variant after six months, but the antibodies still remained effective against the variant in laboratory tests, according to a Jan. 26 study in the New England Journal of Medicine. Assessing how...
By Ernie Mundell HealthDay Reporter Two more Moderna COVID vaccine reactions. Photo: JAMA Network WEDNESDAY, May 12, 2021 (HealthDay News) — In rare cases, people who receive the two-dose Moderna COVID-19 vaccine may experience a red, itchy patch of skin a few days later at the injection site, a new report finds. They shouldn’t panic:...
by Beth Duff-Brown, Stanford University Medical Center Credit: Pixabay/CC0 Public Domain When the delta variant of the coronavirus hit the Sierra Conservation Center—a low- to medium-security prison for men in California—residents who had received the Moderna vaccine were well protected against symptomatic infection, according to Stanford-led research. The study, published in the New England Journal of Medicine,...
By Jocelyn Solis-Moreira Sep 30 2021 Coronavirus research has shown that higher viral loads are associated with severe COVID-19 infection. But new results from the phase III Coronavirus Efficacy (COVE) clinical trial find the Moderna vaccine reduces severe acute respiratory coronavirus 2 (SARS-CoV-2) viral load and viral shedding. In addition to lower viral loads, the vaccine decreased...
by Amanda Ferguson, University of Toronto Credit: Unsplash/CC0 Public Domain Early results from a new study led by researchers from the University of Toronto and Sinai Health reveals subtle differences between the immune responses of long-term care residents receiving the Pfizer-BioNTech and Moderna vaccines. The research, which has not yet been peer-reviewed, suggests that long-term care residents in Ontario...
By Sally Robertson, B.Sc. Jan 26 2021 Researchers in the United States have conducted a study showing that Moderna’s mRNA-1273 vaccine neutralizes all circulating variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tested to date. The novel SARS-CoV-2 virus is the agent responsible for the coronavirus disease 2019 (COVID-19) pandemic that has now caused...
by Lauran Neergaard and Matthew Perrone In this July 27, 2020, file photo, a nurse prepares a shot as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. The U.S. is poised to give the green light as early as Friday, Dec....
